Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-09T15:56:12.800Z Has data issue: false hasContentIssue false

11 - Developing translational animal models of cancer-related fatigue

from Section 2 - Cancer Symptom Mechanisms and Models: Clinical and Basic Science

Published online by Cambridge University Press:  05 August 2011

By
Mary W. Meagher
Edited by
Charles S. Cleeland ,
Michael J. Fisch  and
Adrian J. Dunn
Mary W. Meagher
Affiliation:
Texas A&M University
Charles S. Cleeland
Affiliation:
University of Texas, M. D. Anderson Cancer Center
Michael J. Fisch
Affiliation:
University of Texas, M. D. Anderson Cancer Center
Adrian J. Dunn
Affiliation:
University of Hawaii, Manoa
Get access

Summary

Behavioral symptoms, including fatigue, depression, sleep disturbance, and cognitive alterations, are prevalent among patients with cancer and may be induced by both cancer and its treatment. Fatigue is the most prevalent and distressing of these behavioral symptoms. Cancer-related fatigue (CRF) and associated behavioral disturbances cause profound functional impairments that can persist for years after treatment ends. Nevertheless, the pathogenic mechanisms that mediate CRF remain poorly understood, and current therapies are only partially effective in reducing symptom burden. Progress has been seriously hindered by the lack of appropriate animal models.

Recent evidence suggests that CRF may be conceptualized as a “sickness behavior” that is mediated in part by the central effects of inflammatory cytokines. Sickness behaviors reflect the activity of a central perceptual-affective-motivational system that reorganizes behavior to promote survival. However, under conditions of chronic activation these inflammatory signals are maladaptive and may contribute to the development of persistent fatigue and associated behavioral disturbances in patients with cancer. The constructs of fatigue and sickness contain multiple psychological components that appear to be mediated by distinct molecular, cellular, and neural systems. Advancing our understanding of the neural basis of CRF will require the development of translational measures that parse fatigue and sickness into their specific psychological components using well-validated animal models. Although other biological mechanisms are likely to contribute to the development of CRF (see Chapter 10), the cytokine hypothesis will be used to illustrate how animal models can help researchers evaluate potential mechanisms.

Type
Chapter
Information
Cancer Symptom Science
Measurement, Mechanisms, and Management
 , pp. 124 - 141
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bower, JE. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun 21(7):863–871, 2007.CrossRefGoogle ScholarPubMed
Bower, JE. Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 26(5):768–777, 2008.CrossRefGoogle ScholarPubMed
Cella, D, Davis, K, Breitbart, W, Curt, G. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19(14):3385–3391, 2001.CrossRefGoogle Scholar
Wang, XS, Shi, Q, Williams, , et al. Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer 113(8):2102–2109, 2008.CrossRefGoogle ScholarPubMed
Lawrence, DP, Kupelnick, B, Miller, K, Devine, D, Lau, J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr(32):40–50, 2004.CrossRefGoogle ScholarPubMed
Bower, JE, Ganz, PA, Aziz, N, Fahey, JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64(4):604–611, 2002.CrossRefGoogle ScholarPubMed
Bower, JE, Ganz, PA, Aziz, N, Olmstead, R, Irwin, MR, Cole, SW. Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids. Brain Behav Immun 21(3):251–258, 2007.CrossRefGoogle ScholarPubMed
Cleeland, CS, Bennett, GJ, Dantzer, R, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism?Cancer 97(11):2919–2925, 2003.CrossRefGoogle ScholarPubMed
Collado-Hidalgo, A, Bower, JE, Ganz, PA, Cole, SW, Irwin, MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 12(9):2759–2766, 2006.CrossRefGoogle ScholarPubMed
Lee, BN, Dantzer, R, Langley, KE, et al. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11(5):279–292, 2004.CrossRefGoogle ScholarPubMed
Dantzer, R. Cytokine-induced sickness behavior: where do we stand?Brain Behav Immun 15(1):7–24, 2001.CrossRefGoogle ScholarPubMed
Dantzer, R, Kelley, KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21(2):153–160, 2007.CrossRefGoogle ScholarPubMed
Larson, SJ, Dunn, AJ. Behavioral effects of cytokines. Brain Behav Immun 15(4):371–387, 2001.CrossRefGoogle ScholarPubMed
McKinney, WT, Bunney, WE. Animal model of depression. I. Review of evidence: implications for research. Arch Gen Psychiatry 21(2):240–248, 1969.CrossRefGoogle ScholarPubMed
Willner, P. The validity of animal models of depression. Psychopharmacology (Berl) 83(1):1–16, 1984.CrossRefGoogle ScholarPubMed
Geyer, MA, Markou, A. Animal models of psychiatric disorders. In: Bloom, FE, Kupfer, DJ, eds. Psychopharmacology: the Fourth Generation of Progress. New York: Raven Press, 1995:787–798.Google Scholar
Dietrich, J, Han, R, Yang, Y, Mayer-Pröschel, M, Noble, M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 5(7):22.1–22.23, 2006.CrossRefGoogle ScholarPubMed
Han, R, Yang, YM, Dietrich, J, Luebke, A, Mayer-Pröschel, M, Noble, M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol 7(4):12.1–12.22, 2008.CrossRefGoogle ScholarPubMed
Anisimov, VN, Ukraintseva, SV, Yashin, AI. Cancer in rodents: does it tell us about cancer in humans?Nat Rev Cancer 5(10):807–819, 2005.CrossRefGoogle ScholarPubMed
Gutmann, DH, Hunter-Schaedle, K, Shannon, KM. Harnessing preclinical mouse models to inform human clinical cancer trials. J Clin Invest 116(4):847–852, 2006.CrossRefGoogle ScholarPubMed
Sharpless, NE, DePinho, RA. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 5(9):741–754, 2006.CrossRefGoogle ScholarPubMed
McKinney, WT. Animal models of depression: an overview. Psychiatr Dev 2(2):77–96, 1984.Google ScholarPubMed
Sarhill, N, Walsh, D, Nelson, KA, Homsi, J, Legrand, S, Davis, MP. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study. Am J Hosp Palliat Care 18(3):187–192, 2001.CrossRefGoogle ScholarPubMed
Sugawara, Y, Akechi, T, Shima, Y, et al. Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study. Palliat Med 16(3):261–263, 2002.CrossRefGoogle ScholarPubMed
Escalante, CP. Treatment of cancer-related fatigue: an update. Support Care Cancer 11(2):79–83, 2003.Google ScholarPubMed
Cullum, JL, Wojciechowski, AE, Pelletier, G, Simpson, JS. Bupropion sustained release treatment reduces fatigue in cancer patients. Can J Psychiatry 49(2):139–144, 2004.CrossRefGoogle ScholarPubMed
Moss, EL, Simpson, JS, Pelletier, G, Forsyth, P. An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. Psychooncology 15(3):259–267, 2006.CrossRefGoogle ScholarPubMed
Kubera, M, Holan, V, Mathison, R, Maes, M. The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice. Psychoneuroendocrinology 25(8):785–797, 2000.CrossRefGoogle ScholarPubMed
Kubera, M, Maes, M, Kenis, G, Kim, YK, Lason, W. Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6. Psychiatry Res 134(3):251–258, 2005.CrossRefGoogle ScholarPubMed
Cronbach, LJ, Meehl, PE. Construct validity in psychological tests. Psychol Bull 52(4):281–302, 1955.CrossRefGoogle ScholarPubMed
Campbell, DT, Fiske, DW. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 56(2):81–105, 1959.CrossRefGoogle ScholarPubMed
Mills, PJ, Parker, BA, Dimsdale, JE, Sadler, GR, Ancoli-Israel, S. The relationship between fatigue, quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. Biol Psychol 69(1):85–96, 2005.CrossRefGoogle ScholarPubMed
Markou, A, Chiamulera, C, Geyer, MA, Tricklebank, M, Steckler, T. Removing obstacles in neuroscience drug discovery: the future path for animal models. Neuropsychopharmacology 34(1):74–89, 2009.CrossRefGoogle ScholarPubMed
Malik, NM, Moore, GB, Smith, G, Liu, YL, Sanger, GJ, Andrews, PL. Behavioural and hypothalamic molecular effects of the anti-cancer agent cisplatin in the rat: a model of chemotherapy-related malaise?Pharmacol Biochem Behav 83(1):9–20, 2006.CrossRefGoogle ScholarPubMed
Wood, LJ, Nail, LM, Perrin, NA, Elsea, CR, Fischer, A, Druker, BJ. The cancer chemotherapy drug etoposide (VP-16) induces proinflammatory cytokine production and sickness behavior-like symptoms in a mouse model of cancer chemotherapy-related symptoms. Biol Res Nurs 8(2):157–169, 2006.CrossRefGoogle Scholar
Carmichael, MD, Davis, JM, Murphy, EA, et al. Recovery of running performance following muscle-damaging exercise: relationship to brain IL-1beta. Brain Behav Immun 19(5):445–452, 2005.CrossRefGoogle ScholarPubMed
Sachdeva, AK, Kuhad, A, Tiwari, V, Chopra, K. Epigallocatechin gallate ameliorates chronic fatigue syndrome in mice: behavioral and biochemical evidence. Behav Brain Res 205(2):414–420, 2009.CrossRefGoogle ScholarPubMed
Pyter, LM, Pineros, V, Galang, JA, McClintock, MK, Prendergast, BJ. Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation. Proc Natl Acad Sci U S A 106(22):9069–9074, 2009.CrossRefGoogle ScholarPubMed
Grill, HJ, Norgren, R. The taste reactivity test. I. Mimetic responses to gustatory stimuli in neurologically normal rats. Brain Res 143(2):263–279, 1978.CrossRefGoogle ScholarPubMed
Bluthé, RM, Michaud, B, Poli, V, Dantzer, R. Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol Behav 70(3–4):367–373, 2000.CrossRefGoogle ScholarPubMed
Moy, SS, Nadler, JJ, Young, NB, et al. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 176(1):4–20, 2007.CrossRefGoogle ScholarPubMed
Avitsur, R, Cohen, E, Yirmiya, R. Effects of interleukin-1 on sexual attractivity in a model of sickness behavior. Physiol Behav 63(1):25–30, 1997.CrossRefGoogle Scholar
Larson, SJ, Romanoff, RL, Dunn, AJ, Glowa, JR. Effects of interleukin-1beta on food-maintained behavior in the mouse. Brain Behav Immun 16(4):398–410, 2002.CrossRefGoogle ScholarPubMed
Salamone, JD, Steinpreis, RE, McCullough, LD, Smith, P, Grebel, D, Mahan, K. Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology (Berl) 104(4):515–521, 1991.CrossRefGoogle Scholar
Deacon, RMJ. Assessing nest building in mice. Nat Protoc 1(3):1117–1119, 2006.CrossRefGoogle ScholarPubMed
Deacon, RMJ. Burrowing: a sensitive behavioural assay, tested in five species of laboratory rodents. Behav Brain Res 200(1):128–133, 2009.CrossRefGoogle ScholarPubMed
Ferris, CF, Stolberg, T. Imaging the immediate non-genomic effects of stress hormone on brain activity. Psychoneuroendocrinology 35(1):5–14, 2010.CrossRefGoogle ScholarPubMed
Crawley, JN. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 835(1):18–26, 1999.CrossRefGoogle ScholarPubMed
Nevins, ME, Nash, SA, Beardsley, PM. Quantitative grip strength assessment as a means of evaluating muscle relaxation in mice. Psychopharmacology (Berl) 110(1–2):92–96, 1993.CrossRefGoogle ScholarPubMed
Taylor, AN, Rahman, SU, Tio, DL, et al. Lasting neuroendocrine-immune effects of traumatic brain injury in rats. J Neurotrauma 23(12):1802–1813, 2006.CrossRefGoogle ScholarPubMed
Olivadoti, MD, Opp, MR. Effects of i.c.v. administration of interleukin-1 on sleep and body temperature of interleukin-6-deficient mice. Neuroscience 153(1):338–348, 2008.CrossRefGoogle ScholarPubMed
Lockey, AJ, Kavaliers, M, Ossenkopp, KP. Lipopolysaccharide produces dose-dependent reductions of the acoustic startle response without impairing prepulse inhibition in male rats. Brain Behav Immun 23(1):101–107, 2009.CrossRefGoogle ScholarPubMed
Gandal, MJ, Ehrlichman, RS, Rudnick, ND, Siegel, SJ. A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice. Neuroscience 157(1):95–104, 2008.CrossRefGoogle ScholarPubMed
Winocur, G, Vardy, J, Binns, MA, Kerr, L, Tannock, I. The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol Biochem Behav 85(1):66–75, 2006.CrossRefGoogle ScholarPubMed
Brigman, JL, Rothblat, . Stimulus specific deficit on visual reversal learning after lesions of medial prefrontal cortex in the mouse. Behav Brain Res 187(2):405–410, 2008.CrossRefGoogle ScholarPubMed
Buhusi, CV, Meck, WH. Interval timing with gaps and distracters: evaluation of the ambiguity, switch, and time-sharing hypotheses. J Exp Psychol Anim Behav Process 32(3):329–338, 2006.CrossRefGoogle ScholarPubMed
Gould, TD, Gottesman, II. Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav 5(2):113–119, 2006.CrossRefGoogle ScholarPubMed
Cadenhead, KS, Swerdlow, NR, Braff, DL. Relative risk of prepulse inhibition deficits in schizophrenia patients and their siblings [abstract]. Society of Biological Psychiatry 56th Annual Meeting, New Orleans LA, May 3–5, 2001. Biol Psychiatry 49(8 Suppl 1):126S, 2001. Abstract 439.Google Scholar
Touma, C, Fenzl, T, Ruschel, J, et al. Rhythmicity in mice selected for extremes in stress reactivity: behavioural, endocrine and sleep changes resembling endophenotypes of major depression. PLoS One 4(1):e4325, 2009.CrossRefGoogle ScholarPubMed
Kirkova, J, Walsh, D. Cancer symptom clusters – a dynamic construct. Support Care Cancer 15(9):1011–1013, 2007.CrossRefGoogle ScholarPubMed
Roscoe, JA, Morrow, GR, Hickok, JT, et al. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer 10(4):329–336, 2002.CrossRefGoogle ScholarPubMed
Mulrooney, DA, Ness, KK, Neglia, JP, et al. Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS). Sleep 31(2):271–281, 2008.CrossRefGoogle Scholar
Ray, M, Rogers, LQ, Trammell, RA, Toth, . Fatigue and sleep during cancer and chemotherapy: translational rodent models. Comp Med 58(3):234–245, 2008.Google ScholarPubMed
Beck, SL, Berger, AM, Barsevick, AM, Wong, B, Stewart, KA, Dudley, WN. Sleep quality after initial chemotherapy for breast cancer. Support Care Cancer: e-pub ahead of print, 2009.Google ScholarPubMed
Berger, AM, Wielgus, K, Hertzog, M, Fischer, P, Farr, L. Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. Support Care Cancer: e-pub ahead of print, 2009.Google ScholarPubMed
Young, JW, Minassian, A, Paulus, MP, Geyer, MA, Perry, W. A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neurosci Biobehav Rev 31(6):882–896, 2007.CrossRefGoogle ScholarPubMed
Berridge, KC, Robinson, TE. Parsing reward. Trends Neurosci 26(9):507–513, 2003.CrossRefGoogle ScholarPubMed
LeDoux, JE. The Emotional Brain: the Mysterious Underpinnings of Emotional Life. New York: Simon & Schuster, 1996.Google Scholar
Phelps, EA. Emotion and cognition: insights from studies of the human amygdala. Annu Rev Psychol 57:27–53, 2006.CrossRefGoogle ScholarPubMed
Phelps, EA, LeDoux, JE. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48(2):175–187, 2005.CrossRefGoogle ScholarPubMed
Miller, AH, Ancoli-Israel, S, Bower, JE, Capuron, L, Irwin, MR. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26(6):971–982, 2008.CrossRefGoogle ScholarPubMed
Majer, M, Welberg, , Capuron, L, Pagnoni, G, Raison, CL, Miller, AH. IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain Behav Immun 22(6):870–880, 2008.CrossRefGoogle ScholarPubMed
Miller, AH. Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun 23(2):149–158, 2009.CrossRefGoogle Scholar
Kos, D, Kerckhofs, E, Nagels, G, D'hooghe, MB, Ilsbroukx, S. Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair 22(1):91–100, 2008.CrossRefGoogle ScholarPubMed
Levy, MR. Cancer fatigue: a neurobiological review for psychiatrists. Psychosomatics 49(4):283–291, 2008.CrossRefGoogle ScholarPubMed
Leocani, L, Colombo, B, Comi, G. Physiopathology of fatigue in multiple sclerosis. Neurol Sci 29(Suppl 2):S241–S243, 2008.CrossRefGoogle ScholarPubMed
Serhan, CN, Brain, SD, Buckley, CD, et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J 21(2):325–332, 2007.CrossRefGoogle ScholarPubMed
Malik, NM, Liu, YL, Cole, N, Sanger, GJ, Andrews, PL. Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats. Eur J Pharmacol 555(2–3):164–173, 2007.CrossRefGoogle Scholar
Elsea, CR, Roberts, DA, Druker, BJ, Wood, LJ. Inhibition of p38 MAPK suppresses inflammatory cytokine induction by etoposide, 5-fluorouracil, and doxorubicin without affecting tumoricidal activity. PLoS One 3(6):e2355, 2008.CrossRefGoogle ScholarPubMed
Hermes, GL, Delgado, B, Tretiakova, M, et al. Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumors. Proc Natl Acad Sci U S A 106(52):22393–22398, 2009.CrossRefGoogle ScholarPubMed
Hermes, GL, McClintock, MK. Isolation and the timing of mammary gland development, gonadarche, and ovarian senescence: implications for mammary tumor burden. Dev Psychobiol 50(4):353–360, 2008.CrossRefGoogle ScholarPubMed
Williams, JB, Pang, D, Delgado, B, et al. A model of gene-environment interaction reveals altered mammary gland gene expression and increased tumor growth following social isolation. Cancer Prev Res (Phila Pa) 2(10):850–861, 2009.CrossRefGoogle ScholarPubMed
Deacon, RMJ. Burrowing in rodents: a sensitive method for detecting behavioral dysfunction. Nat Protoc 1(1):118–121, 2006.CrossRefGoogle ScholarPubMed
Burne, TH, Johnston, AN, McGrath, JJ, Mackay-Sim, A. Swimming behaviour and post-swimming activity in Vitamin D receptor knockout mice. Brain Res Bull 69(1):74–78, 2006.CrossRefGoogle ScholarPubMed
Carmichael, MD, Davis, JM, Murphy, EA, et al. Role of brain macrophages on IL-1beta and fatigue following eccentric exercise-induced muscle damage. Brain Behav Immun 24(4): 564–568, 2010.CrossRefGoogle ScholarPubMed
Davis, JM, Murphy, EA, Carmichael, MD, et al. Curcumin effects on inflammation and performance recovery following eccentric exercise-induced muscle damage. Am J Physiol Regul Integr Comp Physiol 292(6):R2168–R2173, 2007.CrossRefGoogle ScholarPubMed
Sachdeva, AK, Kuhad, A, Tiwari, V, Arora, V, Chopra, K. Protective effect of epigallocatechin gallate in murine water-immersion stress model of chronic fatigue syndrome. Basic Clin Pharmacol Toxicol: e-pub ahead of print, 2010.CrossRefGoogle ScholarPubMed
Meagher, MW, Johnson, RR, Young, EE, et al. Interleukin-6 as a mechanism for the adverse effects of social stress on acute Theiler's virus infection. Brain Behav Immun 21(8):1083–1095, 2007.CrossRefGoogle ScholarPubMed
Berridge, KC. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl) 191(3):391–431, 2007.CrossRefGoogle ScholarPubMed
Berridge, KC, Robinson, TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?Brain Res Brain Res Rev 28(3):309–369, 1998.CrossRefGoogle ScholarPubMed
Holmes, JE, Miller, NE. Effects of bacterial endotoxin on water intake, food intake, and body temperature in the albino rat. J Exp Med 118:649–658, 1963.CrossRefGoogle ScholarPubMed
Miller, NE. Some psychophysiological studies of the motivation and of the behavioral effects of illness. Bull British Psychol Soc 17:1–20, 1964.Google Scholar
Hodos, W. Progressive ratio as a measure of reward strength. Science 134:943–944, 1961.CrossRefGoogle ScholarPubMed
Richardson, NR, Roberts, DC. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66(1):1–11, 1996.CrossRefGoogle ScholarPubMed
Merali, Z, Brennan, K, Brau, P, Anisman, H. Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant and gender effects on responding for “free chow” and “earned” sucrose intake. Psychopharmacology (Berl) 165(4):413–418, 2003.CrossRefGoogle ScholarPubMed
Barr, AM, Phillips, AG. Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement. Psychopharmacology (Berl) 141(1):99–106, 1999.CrossRefGoogle ScholarPubMed
Stoops, WW. Reinforcing effects of stimulants in humans: sensitivity of progressive-ratio schedules. Exp Clin Psychopharmacol 16(6):503–512, 2008.CrossRefGoogle ScholarPubMed
Stoops, WW, Glaser, PE, Fillmore, MT, Rush, CR. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol 18(4):534–543, 2004.CrossRefGoogle ScholarPubMed
Comer, SD, Ashworth, JB, Foltin, RW, Johanson, CE, Zacny, JP, Walsh, SL. The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend 96(1–2):1–15, 2008.CrossRefGoogle ScholarPubMed
Stafford, D, LeSage, MG, Glowa, JR. Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology (Berl) 139(3):169–184, 1998.CrossRefGoogle ScholarPubMed
Salamone, JD, Correa, M. Dopamine/adenosine interactions involved in effort-related aspects of food motivation. Appetite 53(3):422–425, 2009.CrossRefGoogle ScholarPubMed
Seigers, R, Schagen, SB, Coppens, CM, et al. Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats. Behav Brain Res 201(2):279–284, 2009.CrossRefGoogle ScholarPubMed
Pugh, CR, Kumagawa, K, Fleshner, M, Watkins, LR, Maier, SF, Rudy, JW. Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain Behav Immun 12(3):212–229, 1998.CrossRefGoogle ScholarPubMed
Bach, ME, Simpson, EH, Kahn, L, Marshall, JJ, Kandel, ER, Kellendonk, C. Transient and selective overexpression of D2 receptors in the striatum causes persistent deficits in conditional associative learning. Proc Natl Acad Sci U S A 105(41):16027–16032, 2008.CrossRefGoogle ScholarPubMed
Kellendonk, C, Simpson, EH, Polan, HJ, et al. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49(4):603–615, 2006.CrossRefGoogle ScholarPubMed
Ward, RD, Kellendonk, C, Simpson, EH, et al. Impaired timing precision produced by striatal D2 receptor overexpression is mediated by cognitive and motivational deficits. Behav Neurosci 123(4):720–730, 2009.CrossRefGoogle ScholarPubMed
Drew, MR, Simpson, EH, Kellendonk, C, et al. Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing. J Neurosci 27(29):7731–7739, 2007.CrossRefGoogle ScholarPubMed
Davison, M, McCarthy, D. The interaction of stimulus and reinforcer control in complex temporal discrimination. J Exp Anal Behav 48(1):97–116, 1987.CrossRefGoogle ScholarPubMed
Jean-Louis, G, Kripke, DF, Cole, RJ, Assmus, JD, Langer, RD. Sleep detection with an accelerometer actigraph: comparisons with polysomnography. Physiol Behav 72(1–2):21–28, 2001.CrossRefGoogle ScholarPubMed
Karl, T, Pabst, R, Hörsten, S. Behavioral phenotyping of mice in pharmacological and toxicological research. Exp Toxicol Pathol 55(1):69–83, 2003.CrossRefGoogle ScholarPubMed
Smith, DR, Burruss, DR, Johnson, AW. An assessment of olfaction and responses to novelty in three strains of mice. Behav Brain Res 201(1):22–28, 2009.CrossRefGoogle Scholar
Garcia, JM, Cata, JP, Dougherty, PM, Smith, RG. Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia. Endocrinology 149(2):455–460, 2008.CrossRefGoogle ScholarPubMed
Sieve, AN, Steelman, AJ, Young, CR, et al. Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice. J Neuroimmunol 155(1–2):103–118, 2004.CrossRefGoogle ScholarPubMed
Brydon, L, Harrison, NA, Walker, C, Steptoe, A, Critchley, HD. Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry 63(11):1022–1029, 2008.CrossRefGoogle ScholarPubMed
Harrison, NA, Brydon, L, Walker, C, et al. Neural origins of human sickness in interoceptive responses to inflammation. Biol Psychiatry 66(5):415–422, 2009.CrossRefGoogle ScholarPubMed
Harrison, NA, Brydon, L, Walker, C, Gray, MA, Steptoe, A, Critchley, HD. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 66(5):407–414, 2009.CrossRefGoogle ScholarPubMed
Filippi, M, Rocca, MA, Colombo, B, et al. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 15(3):559–567, 2002.CrossRefGoogle ScholarPubMed
DeLuca, J, Genova, HM, Hillary, FG, Wylie, G. Neural correlates of cognitive fatigue in multiple sclerosis using functional MRI. J Neurol Sci 270(1–2):28–39, 2008.CrossRefGoogle ScholarPubMed
Lange, G, Steffener, J, Cook, DB, et al. Objective evidence of cognitive complaints in chronic fatigue syndrome: a BOLD fMRI study of verbal working memory. Neuroimage 26(2):513–524, 2005.CrossRefGoogle ScholarPubMed
Cook, DB, O'Connor, PJ, Lange, G, Steffener, J. Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls. Neuroimage 36(1):108–122, 2007.CrossRefGoogle ScholarPubMed
Chaudhuri, A, Behan, PO. Fatigue and basal ganglia. J Neurol Sci 179(S 1–2):34–42, 2000.CrossRefGoogle ScholarPubMed
Rocca, MA, Agosta, F, Colombo, B, et al. fMRI changes in relapsing-remitting multiple sclerosis patients complaining of fatigue after IFNbeta-1a injection. Hum Brain Mapp 28(5):373–382, 2007.CrossRefGoogle ScholarPubMed
Stone, EA, Lehmann, ML, Lin, Y, Quartermain, D. Depressive behavior in mice due to immune stimulation is accompanied by reduced neural activity in brain regions involved in positively motivated behavior. Biol Psychiatry 60(8):803–811, 2006.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×